共 228 条
[1]
Brat DJ(2015)Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas N Engl J Med 372 2481-2498
[2]
Verhaak RG(2016)Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse Glioma Cell 164 550-563
[3]
Aldape KD(2015)Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors N Engl J Med 372 2499-2508
[4]
Yung WK(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820
[5]
Salama SR(2019)Tumor mutational load predicts survival after immunotherapy across multiple cancer types Nat Genet 51 202-206
[6]
Cooper LA(2018)Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy Science 362 eaar3593-3006
[7]
Rheinbay E(2018)Tumor mutation burden as a biomarker in resected non-small-cell lung Cancer J Clin Oncol 36 2995-699
[8]
Miller CR(2018)Clinical Impact of Tumor Mutational Burden in Neuroblastoma JNCI: Journal of the National Cancer Institute 111 695-1236
[9]
Vitucci M(2017)Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden Genome Med 9 34-641
[10]
Ceccarelli M(2016)Immunogenomics of Hypermutated Glioblastoma: a patient with Germline POLE deficiency treated with checkpoint blockade immunotherapy Cancer Discov 6 1230-421